Market Scope Market Dynamics Drivers R&D in innovative devices The rising prevalence of diseases has been attracting attention to healthcare solutions that can help individuals
It is not intended for use as a drug, food, or cosmetic, and must not be misused, mislabeled, or misrepresented as such
Moreover, OW semaglutide 2.4 mg was associated with a consistent benefit in HF composite endpoint, comprising death from CV causes or hospitalization or an urgent medical visit for HF (HR 0.82, 95% CI, 0.710.96), and death from any cause (HR 0.81, 95% CI, 0.710.93) 84
B12+MIC supports increased energy and reduced fatigue, enhanced fat metabolism, improved mood and mental clarity, liver health and detoxification, and better nutrient absorption